Results 51 to 60 of about 4,442,613 (109)

Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparison

Acta Oncologica
Background and purpose: Regional nodal irradiation (RNI) for breast cancer delivers radiation in proximity to the shoulder and torso, and radiation exposure may contribute to long-term upper extremity and postural morbidity.
Jessica F. Burlile, Satomi Shiraishi, Heather J. Gunn, Jennifer L. Bradt, Haley M. Kroeplin, Karen G. Lang, Jenna K. Cimmiyotti, Nicolas Depauw, Connie Y. Chang, Kevin M. Brom, Cassandra L. Sonnicksen, Anhmai Vu, Rachel B. Jimenez, Kimberly S. Corbin   +13 more
doaj   +1 more source

Letter. Intensity-modulated radiotherapy for the treatment of breast cancer [PDF]

, 2013
In the systematic review of intensity-modulated radiotherapy (IMRT) in the treatment of breast cancer reported in Clinical Oncology by Dayes and colleagues [1], the only prospective randomised clinical trial (n = 306) testing forward-planned IMRT to have
Haviland, J.S., Coles, C.E., Donovan, E., Yarnold, J.   +3 more
core   +1 more source

Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer

Radiation Oncology, 2018
Background The principle aim of this study is to incorporate 4DCT ventilation imaging into functional treatment planning that preserves high-functioning lung with both double scattering and scanning beam techniques in proton therapy.
Qijie Huang, Salma K. Jabbour, Zhiyan Xiao, Ning Yue, Xiao Wang, Hongbin Cao, Yu Kuang, Yin Zhang, Ke Nie   +8 more
doaj   +1 more source

Dosimetric advantages of proton beam therapy compared to intensity-modulated radiation therapy for retroperitoneal chordoma

Rare Tumors, 2019
Retroperitoneal chordomas are exceedingly rare and account for less than 5% of all primary bone malignancies. Their etiology remains unknown. We report a rare case of an extravertebral chordoma of the retroperitoneum in a 71-year-old man treated with ...
Nathan Y Yu, Sujay A Vora
doaj   +1 more source

Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy

Advances in Radiation Oncology, 2022
Purpose: While intensity modulated proton therapy can deliver simultaneous integrated boost (SIB) to the dominant intraprostatic lesion (DIL) with high precision, it is sensitive to anatomic changes.
Jun Zhou, PhD, Xiaofeng Yang, PhD, Chih-Wei Chang, PhD, Sibo Tian, MD, Tonghe Wang, PhD, Liyong Lin, PhD, Yinan Wang, MS, James Robert Janopaul-Naylor, MD, Pretesh Patel, MD, John D. Demoor, MS, Duncan Bohannon, MS, Alex Stanforth, MS, Bree Eaton, MD, Mark W. McDonald, MD, Tian Liu, PhD, Sagar Anil Patel, MD   +15 more
doaj   +1 more source

Patient-specific quality assurance and plan complexity: from photon standardisation to the unique characteristics of particle therapy

Frontiers in Physics
Patient-specific quality assurance (PSQA) is a safety barrier ensuring that treatment plans calculated by the Treatment Planning System (TPS) are accurately delivered by the machine.
Maxence Rayer, Maxence Rayer, Maxence Rayer, Daniel Maneval, Cyril Moignier, Thomas Tessonnier, Dorothée Lebhertz, Anthony Vela, Gary Delattre, Laetitia Lechippey, Alain Batalla, Aurélien Corroyer-Dulmont, Aurélien Corroyer-Dulmont, Aurélien Corroyer-Dulmont   +13 more
doaj   +1 more source

Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study

, 2012
Rectal toxicity is a serious adverse effect in early-stage prostate cancer patients treated with curative radiation therapy (RT). Injecting a spacer between Denonvilliers' fascia increases the distance between the prostate and the anterior rectal wall ...
Cozzi, Luca, Zilli, Thomas, Vallée, Jean-Paul, Weber, Damien, Miralbell, Raymond, Rouzaud, Michel, Vallee JP, Cozzi L, Weber DC, Miralbell R, Rouzaud M, Zilli T   +11 more
core   +1 more source

Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp

Technology in Cancer Research & Treatment, 2021
Objective: We compared radiotherapy plans among helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), and intensity-modulated proton therapy (IMPT) for angiosarcoma of the scalp (AS).
Tomoki Mizuno MD, Natsuo Tomita MD, PhD, Taiki Takaoka MD, PhD, Masashi Tomida RTT, Hiroshi Fukuma RTT, Takahiro Tsuchiya RTT, Yuta Shibamoto MD, PhD   +6 more
doaj   +1 more source

Data from: Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial

, 2018
Background and Purpose Patients with low-grade glioma (LGG) have a prolonged survival expectancy due to better discriminative tumor classification and multimodal treatment. Consequently, long-term treatment toxicity gains importance.
A.W.H. Minken, E.G.C. Troost, E. Roelofs, A. Hoeben, C. Niël, D. Eekers, P. Lambin, M. Cubillos-Mesias, R.Jan Smeenk, J.H.A.M. Kaanders   +9 more
core   +1 more source

Potential normal tissue sparing in vulvar cancer using intensity modulated proton therapy versus volumetric modulated arc therapy

Physics and Imaging in Radiation Oncology
Background and purpose: Photon radiotherapy, typically volumetric modulated arc therapy (VMAT), is the standard for adjuvant or definitive treatment of vulvar cancer.
Anna C. Prins, Raymond de Boer, András G. Zolnay, Remi A. Nout, Mischa S. Hoogeman, Kelvin Ng Wei Siang   +5 more
doaj   +1 more source